IBDEI3AS ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.4) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.4)
;;=^IBE(358.4,
;;^UTILITY(U,$J,358.4,0)
;;=IMP/EXP SELECTION GROUP^358.4I^2545^2545
;;^UTILITY(U,$J,358.4,1,0)
;;=ADMINISTRATIVE PURPOSES^1^1
;;^UTILITY(U,$J,358.4,2,0)
;;=FAMILY CIRCUMSTANCES^2^1
;;^UTILITY(U,$J,358.4,3,0)
;;=HOUSING & ECONOMIC CIRCUM^3^1
;;^UTILITY(U,$J,358.4,4,0)
;;=MENTAL & BEHAVIORAL PROBLEMS^4^1
;;^UTILITY(U,$J,358.4,5,0)
;;=PERSONS SEEKING CONSULT^5^1
;;^UTILITY(U,$J,358.4,6,0)
;;=SCREENING FOR MENTAL/DEVELOPMENT^6^1
;;^UTILITY(U,$J,358.4,7,0)
;;=TEAM CONFERENCE^3^2
;;^UTILITY(U,$J,358.4,8,0)
;;=SOCIAL WORKER^2^2
;;^UTILITY(U,$J,358.4,9,0)
;;=PSYCH^1^2
;;^UTILITY(U,$J,358.4,10,0)
;;=MD/PA/NP-ESTAB PATIENT^1^3
;;^UTILITY(U,$J,358.4,11,0)
;;=MD/PA/NP-NEW PATIENT^2^3
;;^UTILITY(U,$J,358.4,12,0)
;;=NEW PATIENT^3^4
;;^UTILITY(U,$J,358.4,13,0)
;;=ESTABLISHED PATIENT^1^4
;;^UTILITY(U,$J,358.4,14,0)
;;=CONSULTATION^2^4
;;^UTILITY(U,$J,358.4,15,0)
;;=FUNCTIONAL BRAIN MAPPING^2^5
;;^UTILITY(U,$J,358.4,16,0)
;;=CNS ASSESSMENTS/TESTS^1^5
;;^UTILITY(U,$J,358.4,17,0)
;;=ALCOHOL INDUCED MENTAL DISORDERS^1^6
;;^UTILITY(U,$J,358.4,18,0)
;;=DEMENTIAS^3^6
;;^UTILITY(U,$J,358.4,19,0)
;;=DRUG INDUCED MENTAL DISORDERS^3^6
;;^UTILITY(U,$J,358.4,20,0)
;;=OTHER MENTAL/NEURO DISORDERS^4^6
;;^UTILITY(U,$J,358.4,21,0)
;;=PERSISTENT MENTAL DISODERS^5^6
;;^UTILITY(U,$J,358.4,22,0)
;;=TRANSIENT MENTAL DISORDERS^7^6
;;^UTILITY(U,$J,358.4,23,0)
;;=CEREBROVASCULAR DISEASES^2^6
;;^UTILITY(U,$J,358.4,24,0)
;;=SUICIDE IDEATIONS/ATTEMPTS^6^6
;;^UTILITY(U,$J,358.4,25,0)
;;=EEG LTM^1^7
;;^UTILITY(U,$J,358.4,26,0)
;;=EEG PROCEDURAL^3^7
;;^UTILITY(U,$J,358.4,27,0)
;;=EEG ROUTINE^4^7
;;^UTILITY(U,$J,358.4,28,0)
;;=INTRAOPERATIVE EVOKED POTENTIALS^5^7
;;^UTILITY(U,$J,358.4,29,0)
;;=NEUROLOGY/SEIZURE/VNS PROGRAMMING^6^7
;;^UTILITY(U,$J,358.4,30,0)
;;=EEG MONITORING^2^7
;;^UTILITY(U,$J,358.4,31,0)
;;=SEIZURES/EPILEPSY/SPELLS^1^8
;;^UTILITY(U,$J,358.4,32,0)
;;=CEREBROVASCULAR DISEASE^2^8
;;^UTILITY(U,$J,358.4,33,0)
;;=DIZZINESS^3^8
;;^UTILITY(U,$J,358.4,34,0)
;;=ENCEPHALOPATHY^4^8
;;^UTILITY(U,$J,358.4,35,0)
;;=HEADACHE^5^8
;;^UTILITY(U,$J,358.4,36,0)
;;=MOVEMENT DISORDERS^6^8
;;^UTILITY(U,$J,358.4,37,0)
;;=NEOPLASMS^7^8
;;^UTILITY(U,$J,358.4,38,0)
;;=NEURODEGENERATIVE DISEASE^8^8
;;^UTILITY(U,$J,358.4,39,0)
;;=SLEEP DISORDERS^9^8
;;^UTILITY(U,$J,358.4,40,0)
;;=SPECIAL SCREENING^10^8
;;^UTILITY(U,$J,358.4,41,0)
;;=OTHER^11^8
;;^UTILITY(U,$J,358.4,42,0)
;;=EDUCATION^2^9
;;^UTILITY(U,$J,358.4,43,0)
;;=MEDICAL NUTRITION THERAPY^3^9
;;^UTILITY(U,$J,358.4,44,0)
;;=TEAM CONFERENCE^7^9
;;^UTILITY(U,$J,358.4,45,0)
;;=ASSESSMENT^1^9
;;^UTILITY(U,$J,358.4,46,0)
;;=MEDICATION THERAPY MANAGEMENT^4^9
;;^UTILITY(U,$J,358.4,47,0)
;;=PHYSICAL THERAPY^5^9
;;^UTILITY(U,$J,358.4,48,0)
;;=PROLONGED CLINICAL STAFF SERVICES^6^9
;;^UTILITY(U,$J,358.4,49,0)
;;=NEW PATIENT^2^10
;;^UTILITY(U,$J,358.4,50,0)
;;=ESTABLISHED PATIENT^1^10
;;^UTILITY(U,$J,358.4,51,0)
;;=CONSULTATIONS^3^10
;;^UTILITY(U,$J,358.4,52,0)
;;=BODY MASS INDEX (BMI)^1^11
;;^UTILITY(U,$J,358.4,53,0)
;;=COUNSELING^2^11
;;^UTILITY(U,$J,358.4,54,0)
;;=DIABETES W/O COMPLICATION^3^11
;;^UTILITY(U,$J,358.4,55,0)
;;=OVERWEIGHT/OBESITY^4^11
;;^UTILITY(U,$J,358.4,56,0)
;;=SUICIDE IDEATIONS/ATTEMPTS^5^11
;;^UTILITY(U,$J,358.4,57,0)
;;=EDUCATION/TRAINING^1^12
;;^UTILITY(U,$J,358.4,58,0)
;;=PROCEDURE CODES-GROUP^4^12
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI3AS 3804 printed Nov 22, 2024@17:55:17 Page 2
IBDEI3AS ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.4)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.4)
+2 ;;=^IBE(358.4,
+3 ;;^UTILITY(U,$J,358.4,0)
+4 ;;=IMP/EXP SELECTION GROUP^358.4I^2545^2545
+5 ;;^UTILITY(U,$J,358.4,1,0)
+6 ;;=ADMINISTRATIVE PURPOSES^1^1
+7 ;;^UTILITY(U,$J,358.4,2,0)
+8 ;;=FAMILY CIRCUMSTANCES^2^1
+9 ;;^UTILITY(U,$J,358.4,3,0)
+10 ;;=HOUSING & ECONOMIC CIRCUM^3^1
+11 ;;^UTILITY(U,$J,358.4,4,0)
+12 ;;=MENTAL & BEHAVIORAL PROBLEMS^4^1
+13 ;;^UTILITY(U,$J,358.4,5,0)
+14 ;;=PERSONS SEEKING CONSULT^5^1
+15 ;;^UTILITY(U,$J,358.4,6,0)
+16 ;;=SCREENING FOR MENTAL/DEVELOPMENT^6^1
+17 ;;^UTILITY(U,$J,358.4,7,0)
+18 ;;=TEAM CONFERENCE^3^2
+19 ;;^UTILITY(U,$J,358.4,8,0)
+20 ;;=SOCIAL WORKER^2^2
+21 ;;^UTILITY(U,$J,358.4,9,0)
+22 ;;=PSYCH^1^2
+23 ;;^UTILITY(U,$J,358.4,10,0)
+24 ;;=MD/PA/NP-ESTAB PATIENT^1^3
+25 ;;^UTILITY(U,$J,358.4,11,0)
+26 ;;=MD/PA/NP-NEW PATIENT^2^3
+27 ;;^UTILITY(U,$J,358.4,12,0)
+28 ;;=NEW PATIENT^3^4
+29 ;;^UTILITY(U,$J,358.4,13,0)
+30 ;;=ESTABLISHED PATIENT^1^4
+31 ;;^UTILITY(U,$J,358.4,14,0)
+32 ;;=CONSULTATION^2^4
+33 ;;^UTILITY(U,$J,358.4,15,0)
+34 ;;=FUNCTIONAL BRAIN MAPPING^2^5
+35 ;;^UTILITY(U,$J,358.4,16,0)
+36 ;;=CNS ASSESSMENTS/TESTS^1^5
+37 ;;^UTILITY(U,$J,358.4,17,0)
+38 ;;=ALCOHOL INDUCED MENTAL DISORDERS^1^6
+39 ;;^UTILITY(U,$J,358.4,18,0)
+40 ;;=DEMENTIAS^3^6
+41 ;;^UTILITY(U,$J,358.4,19,0)
+42 ;;=DRUG INDUCED MENTAL DISORDERS^3^6
+43 ;;^UTILITY(U,$J,358.4,20,0)
+44 ;;=OTHER MENTAL/NEURO DISORDERS^4^6
+45 ;;^UTILITY(U,$J,358.4,21,0)
+46 ;;=PERSISTENT MENTAL DISODERS^5^6
+47 ;;^UTILITY(U,$J,358.4,22,0)
+48 ;;=TRANSIENT MENTAL DISORDERS^7^6
+49 ;;^UTILITY(U,$J,358.4,23,0)
+50 ;;=CEREBROVASCULAR DISEASES^2^6
+51 ;;^UTILITY(U,$J,358.4,24,0)
+52 ;;=SUICIDE IDEATIONS/ATTEMPTS^6^6
+53 ;;^UTILITY(U,$J,358.4,25,0)
+54 ;;=EEG LTM^1^7
+55 ;;^UTILITY(U,$J,358.4,26,0)
+56 ;;=EEG PROCEDURAL^3^7
+57 ;;^UTILITY(U,$J,358.4,27,0)
+58 ;;=EEG ROUTINE^4^7
+59 ;;^UTILITY(U,$J,358.4,28,0)
+60 ;;=INTRAOPERATIVE EVOKED POTENTIALS^5^7
+61 ;;^UTILITY(U,$J,358.4,29,0)
+62 ;;=NEUROLOGY/SEIZURE/VNS PROGRAMMING^6^7
+63 ;;^UTILITY(U,$J,358.4,30,0)
+64 ;;=EEG MONITORING^2^7
+65 ;;^UTILITY(U,$J,358.4,31,0)
+66 ;;=SEIZURES/EPILEPSY/SPELLS^1^8
+67 ;;^UTILITY(U,$J,358.4,32,0)
+68 ;;=CEREBROVASCULAR DISEASE^2^8
+69 ;;^UTILITY(U,$J,358.4,33,0)
+70 ;;=DIZZINESS^3^8
+71 ;;^UTILITY(U,$J,358.4,34,0)
+72 ;;=ENCEPHALOPATHY^4^8
+73 ;;^UTILITY(U,$J,358.4,35,0)
+74 ;;=HEADACHE^5^8
+75 ;;^UTILITY(U,$J,358.4,36,0)
+76 ;;=MOVEMENT DISORDERS^6^8
+77 ;;^UTILITY(U,$J,358.4,37,0)
+78 ;;=NEOPLASMS^7^8
+79 ;;^UTILITY(U,$J,358.4,38,0)
+80 ;;=NEURODEGENERATIVE DISEASE^8^8
+81 ;;^UTILITY(U,$J,358.4,39,0)
+82 ;;=SLEEP DISORDERS^9^8
+83 ;;^UTILITY(U,$J,358.4,40,0)
+84 ;;=SPECIAL SCREENING^10^8
+85 ;;^UTILITY(U,$J,358.4,41,0)
+86 ;;=OTHER^11^8
+87 ;;^UTILITY(U,$J,358.4,42,0)
+88 ;;=EDUCATION^2^9
+89 ;;^UTILITY(U,$J,358.4,43,0)
+90 ;;=MEDICAL NUTRITION THERAPY^3^9
+91 ;;^UTILITY(U,$J,358.4,44,0)
+92 ;;=TEAM CONFERENCE^7^9
+93 ;;^UTILITY(U,$J,358.4,45,0)
+94 ;;=ASSESSMENT^1^9
+95 ;;^UTILITY(U,$J,358.4,46,0)
+96 ;;=MEDICATION THERAPY MANAGEMENT^4^9
+97 ;;^UTILITY(U,$J,358.4,47,0)
+98 ;;=PHYSICAL THERAPY^5^9
+99 ;;^UTILITY(U,$J,358.4,48,0)
+100 ;;=PROLONGED CLINICAL STAFF SERVICES^6^9
+101 ;;^UTILITY(U,$J,358.4,49,0)
+102 ;;=NEW PATIENT^2^10
+103 ;;^UTILITY(U,$J,358.4,50,0)
+104 ;;=ESTABLISHED PATIENT^1^10
+105 ;;^UTILITY(U,$J,358.4,51,0)
+106 ;;=CONSULTATIONS^3^10
+107 ;;^UTILITY(U,$J,358.4,52,0)
+108 ;;=BODY MASS INDEX (BMI)^1^11
+109 ;;^UTILITY(U,$J,358.4,53,0)
+110 ;;=COUNSELING^2^11
+111 ;;^UTILITY(U,$J,358.4,54,0)
+112 ;;=DIABETES W/O COMPLICATION^3^11
+113 ;;^UTILITY(U,$J,358.4,55,0)
+114 ;;=OVERWEIGHT/OBESITY^4^11
+115 ;;^UTILITY(U,$J,358.4,56,0)
+116 ;;=SUICIDE IDEATIONS/ATTEMPTS^5^11
+117 ;;^UTILITY(U,$J,358.4,57,0)
+118 ;;=EDUCATION/TRAINING^1^12
+119 ;;^UTILITY(U,$J,358.4,58,0)
+120 ;;=PROCEDURE CODES-GROUP^4^12
